Article
The TRiC/CCT Complex at the Crossroads of Metabolism and Hypoxia in GBM: Implications for IDH-Dependent Therapeutic Targeting.
International journal of molecular sciences - 29 Dec 2025
Alberti Giusi, D'Amico Giuseppa, Augello Maria Antonella, Cappello Francesco, Szychlinska Marta Anna, Caruso Bavisotto Celeste, Scalia Federica
Abstract excerpt
Glioblastoma (GBM) is characterized by its unique molecular features, such as self-renewal and tumorigenicity of glioma stem cells that promote resistance, largely resulting in treatment failure. Among the molecular alterations significant to GBM biology and treatment, mutations in isocitrate dehydrogenase (IDH) have assumed particular relevance. IDH-mutant and IDH-wild-type tumors exhibit significantly different...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
